3D printing titanium alloy porous graft carrying functionalized temperature-sensitive chitosan hydrogel as well as preparation method and application of 3D printing titanium alloy porous graft

The preparation of titanium alloy porous grafts carrying functionalized thermosensitive chitosan hydrogels through 3D printing technology, solving the problem of insufficient biocompatibility of traditional titanium alloy stents and achieving the effects of bone regeneration and vascular regeneration.

CN118949123APending Publication Date: 2024-11-15LUOYANG ORTHOPEDIC TRAUMATOLOGICAL HOSPITAL
View PDF 0 Cites 2 Cited by

Patent Information

Application Number
CN202410872856.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-01
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

Traditional solid-state titanium alloy brackets have shortcomings in terms of biocompatibility and non-physical elastic modulus, making it difficult to effectively promote bone integration and vascular regeneration.

Method used

Using 3D printing technology to prepare titanium alloy porous grafts carrying functionalized thermosensitive chitosan hydrogels, manufacture porous titanium alloy scaffolds through electron beam melt deposition technology, and fill their pores with chitosan hydrogels and ICA to promote Osseous integration and vascular regeneration.

Benefits of technology

The biocompatibility improvement and bone regeneration promotion of titanium alloy scaffolds were achieved. Through early mass release and subsequent stable release mode, the proliferation and osteogenic differentiation of bone marrow mesenchymal stem cells were promoted, and the stability of the scaffold and bone interface was improved. .

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118949123A_ABST
    Figure CN118949123A_ABST
Patent Text Reader

Abstract

The invention provides a 3D printing titanium alloy porous graft carrying functionalized temperature-sensitive chitosan hydrogel as well as a preparation method and application thereof, and belongs to the technical field of 3D printing titanium alloy porous grafts of temperature-sensitive chitosan hydrogel. Comprising the steps that Ti-6Al-4v powder is used for manufacturing under the action of a standard operation file converted by a 3D model through an electron beam fused deposition technology, the porosity of the designed stent is 70%, and the pore diameter is 500 microns. The hydrogel in the composite scaffold is degraded to provide a good local administration mode for osseointegration on a prosthesis and host bone interface, wherein the release of ICA is expressed as early mass release and subsequent stable release, and bone regeneration and osseointegration are promoted; the ICA released locally can effectively promote proliferation and osteogenic differentiation of bone marrow mesenchymal stem cells and improve the early stability of a scaffold and a bone interface, and the addition of ICA / thermosensitive chitosan hydrogel in the three-dimensional porous implant is an effective strategy for enhancing bone regeneration and osseointegration.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of 3D printed titanium alloy porous implants of temperature-sensitive chitosan hydrogel, and in particular to a 3D printed titanium alloy porous implant carrying functionalized temperature-sensitive chitosan hydrogel, a preparation method and an application thereof. Background Art

[0002] Large bone defects caused by trauma and tumor resection are a current orthopedic problem. Autologous bone transplantation can be used to treat clinically severe bone defects. However, autologous bone transplantation can cause severe damage to the bone harvesting site and potential poor bone healing, so autologous bone transplantation is not the best treatment. Bone tissue engineering uses bionic scaffold technology to meet the growing clinical needs and is a promising method to induce bone regeneration.

[0003] Titanium and titanium alloys have strong mechanical properties and corrosion resistance and are widely used in orthopedic and dental implant materials. Considering its non-toxic properties and biocompatibility, titanium is one of the best choices for implant applications.

[0004] The biological inertness of titanium alloys leads to a prolonged osteointegration time with bone. To overcome this limitation, surface treatment techniques can be used to obtain a bioactive surface on a titanium substrate. 3D printing is a mature and versatile additive material technology that can manufacture porous implants with precise mechanical properties, good pore structure, and even produce implants with specific patient functional designs. Compared with traditional titanium alloy stents, 3D porous titanium alloy stents printed by electron beam melting (EBM) technology have better biological properties, and can effectively solve the problems of non-physical elastic modulus and insufficient biocompatibility of traditional solid titanium alloy stents. Therefore, a 3D printed titanium alloy / thermosensitive collagen hydrogel system is designed. The system can promote local angiogenesis and bone integration after being loaded with sodium polyphosphate. In vitro experiments have confirmed that the system can slowly release sodium polyphosphate and has good biocompatibility. Chitosan hydrogel reinforced with genipin is used to carry ICA and fill it into the pores and surface of the 3D printed titanium alloy porous stent to promote angiogenesis and bone integration. Therefore, the present application provides a 3D printed titanium alloy porous graft carrying functionalized thermosensitive chitosan hydrogel and a preparation method and application to meet the needs. Summary of the invention

[0005] 1. Technical issues to be resolved

[0006] In view of the deficiencies in the prior art, the present invention provides a 3D printed titanium alloy porous graft carrying functionalized temperature-sensitive chitosan hydrogel, a preparation method and an application thereof, which solve the problems of the non-physical elastic modulus and insufficient biocompatibility of traditional solid titanium alloy stents.

[0007] (II) Technical solution

[0008] In order to solve the above technical problems, the present invention provides the following technical solutions:

[0009] A 3D printed titanium alloy porous implant carrying functionalized temperature-sensitive chitosan hydrogel and a preparation method and application thereof, comprising the following steps:

[0010] 1) Using Ti-6Al-4v powder through electron beam melting deposition technology, the standard operating file of 3D model conversion was used for production. The porosity of the designed stent was 70% and the pore size was 500μm. The 3D printed porous titanium alloy stent was obtained by 3D printing;

[0011] 2) Dissolve chitosan in 1% acetic acid to prepare chitosan solution, and dissolve 0.1 g of β-glycerophosphate powder in 2 mL of 60% ethanol to prepare 50 g / L β-glycerophosphate solution;

[0012] 3) The hydrogel was prepared by mixing chitosan and β-glycerophosphate solution and then vigorously stirring at room temperature for 10 minutes, then pouring 3 mL of the mixed solution into a 35 mL plastic culture dish and placing it in an incubator at 37°C for 48 hours, adding 5 mL of 10 g / L glycine solution to the cross-linked gel, followed by incubation for 2 hours to bind unreacted β-glycerophosphate, then draining the glycine solution and washing the gel 3 times with triple distilled water to obtain chitosan hydrogel.

[0013] Preferably, the 3D printed porous titanium alloy scaffold is a 45-55 μm Ti-6Al-4v powder placed in a 3D printing machine. The scaffold is divided into two types, one is a disc-shaped φ4×L8 mm, which is used for cell experiments; the other is a cylindrical φ10×L3 mm, which is used for animal experiments. The obtained 3D printed porous titanium alloy scaffold is soaked in ethanol and ultrapure water for 45 minutes and circulated three times. The 3D printed porous titanium alloy scaffold needs to be autoclaved before use.

[0014] Preferably, ICA is added to the liquid gel solution and mixed evenly to obtain a mixed solution, wherein the ICA is icariin, and the 3D printed porous titanium alloy stent is immersed in the mixed solution and allowed to stand at 37° C. for 20 minutes to obtain a composite stent after gelation.

[0015] Preferably, the final concentration of ICA in the composite scaffold is 0.1 μmol / mL, followed by a cyclic freeze-drying process, and the obtained freeze-dried sample is observed for microscopic features and structure under a scanning electron microscope.

[0016] Preferably, the rate at which the composite scaffold releases the ICA is evaluated, the composite scaffold is immersed in a 48-well culture plate containing 1 mL of buffer at 37° C., then an equal amount of buffer is replaced at 1 hour, 4 hours, 10 hours, 24 hours, 72 hours, 168 hours, 240 hours and 360 hours, the ICA concentration in the collected buffer is measured using a UV spectrophotometer, and three independent experiments are performed.

[0017] Compared with the prior art, the present invention has at least the following beneficial effects:

[0018] In the above scheme, the degradation of the hydrogel in the composite scaffold provides bone integration at the interface of the prosthesis and the host bone. The release of ICA is manifested as an early large-scale release and a subsequent stable release. The pore size of the scaffold is the direct factor leading to drug release. A larger pore size will accelerate the loss of the drug. Therefore, the early release may be due to the outflow of ICA from the pores. In the subsequent period of time, the release rate is less affected by the pore size. The stable release rate at this stage may be due to the slow degradation of the hydrogel. The ICA in the hydrogel can be continuously released within 15 days. Therefore, this structure is a good local drug delivery method to promote bone regeneration and bone integration. The locally released ICA can effectively promote the proliferation and osteogenic differentiation of bone marrow mesenchymal stem cells and improve the early stability of the scaffold-bone interface. Adding ICA / thermosensitive chitosan hydrogel to three-dimensional porous implants is an effective strategy to enhance bone regeneration and bone integration. BRIEF DESCRIPTION OF THE DRAWINGS

[0019] Figure 1 Microscopic diagram of 3D printed titanium alloy porous graft titanium alloy stent and composite stent carrying functionalized thermosensitive chitosan hydrogel;

[0020] Figure 2 Schematic diagram of 3D printed titanium alloy porous graft carrying functionalized thermosensitive chitosan hydrogel and hydrogel gelation

[0021] Figure 3 Schematic diagram of the degradation rate of chitosan hydrogel and the release rate of ICA and the effect of toxicity on the morphology of bone marrow mesenchymal stem cells in 3D-printed titanium alloy porous grafts carrying functionalized thermosensitive chitosan hydrogel;

[0022] Figure 4 Schematic diagram of evaluating the differentiation of bone marrow mesenchymal stem cells by death staining and cell number ratio and Alizarin red staining and area ratio for 3D printed titanium alloy porous grafts carrying functionalized thermosensitive chitosan hydrogel;

[0023] Figure 5Schematic diagram of the maximum push-out force of Ti, GC-Ti and ICA-GC-Ti after 7-day and 14-day culture of bone marrow mesenchymal stem cells for 3D printed titanium alloy porous implants carrying functionalized thermosensitive chitosan hydrogel, and 6-week and 12-week implantation in the distal femur of rabbits to measure the expression of ALP, BMP-2 and cyanate genes;

[0024] Figure 6 Micro-CT images of 3D printed titanium alloy porous implants carrying functionalized thermosensitive chitosan hydrogel at 6 and 12 weeks of Ti, GC-Ti, and ICA- GC-Ti;

[0025] Figure 7 Immunohistochemical staining of 3D-printed titanium alloy porous grafts carrying functionalized thermosensitive chitosan hydrogel. Ti, GC-Ti and ICA-GC-Ti groups were transplanted into the distal femur of rabbits 6 and 12 weeks after implantation. Col-1 and cyanate were observed at 6 and 12 weeks to evaluate the degree of bone regeneration.

[0026] As shown in the figure, in order to clearly implement the structure of the embodiment of the present invention, specific structures and devices are marked in the figure, but this is only for illustrative purposes and is not intended to limit the present invention to the specific structure, device and environment. According to specific needs, ordinary technicians in this field can adjust or modify these devices and environments. DETAILED DESCRIPTION

[0027] The following is a detailed description of a 3D printed titanium alloy porous implant carrying functionalized thermosensitive chitosan hydrogel, a preparation method and an application provided by the present invention in combination with the accompanying drawings and specific embodiments. At the same time, it is explained here that in order to make the embodiments more detailed, the following embodiments are the best and preferred embodiments, and those skilled in the art may also adopt other alternative methods to implement some known technologies; and the accompanying drawings are only for a more specific description of the embodiments, and are not intended to specifically limit the present invention.

[0028] It should be noted that the references to "one embodiment", "embodiment", "exemplary embodiments", "some embodiments" and the like in the specification indicate that the embodiments described may include specific features, structures or characteristics, but not every embodiment may include the specific features, structures or characteristics. In addition, when a specific feature, structure or characteristic is described in conjunction with an embodiment, it should be within the knowledge of a person skilled in the art to implement such feature, structure or characteristic in conjunction with other embodiments (whether or not explicitly described).

[0029] In general, a term can be understood, at least in part, from its use in context. For example, depending, at least in part, on the context, the term "one or more" as used herein can be used to describe any feature, structure, or characteristic in the singular sense, or can be used to describe a combination of features, structures, or characteristics in the plural sense. Additionally, the term "based on" can be understood as not necessarily intended to convey an exclusive set of factors, but can instead, depending, at least in part, on the context, allow for the presence of other factors that are not necessarily explicitly described.

[0030] It will be understood that the meanings of “on,” “over,” and “above” in the present invention should be interpreted in the broadest manner, so that “on” not only means “directly on” something, but also includes the meaning of being “on” something with intervening features or layers therebetween, and “on” or “over” not only means “on” or “above” something, but also includes the meaning of being “on” or “above” something with no intervening features or layers therebetween.

[0031] Additionally, spatially relative terms such as "under," "beneath," "lower," "above," "upper," and the like may be used herein for descriptive convenience to describe the relationship of one element or feature to another element or features, as shown in the accompanying drawings. Spatially relative terms are intended to encompass different orientations of the device in use or operation in addition to the orientation depicted in the accompanying drawings. The device may be oriented in other ways, and the spatially relative descriptors used herein may be similarly interpreted accordingly.

[0032] like Figure 1-Figure 7 As shown, the embodiment of the present invention provides a 3D printed titanium alloy porous graft carrying functionalized temperature-sensitive chitosan hydrogel and a preparation method and application thereof, comprising the following steps:

[0033] 1) Using Ti-6Al-4v powder through electron beam melting deposition technology, the standard operating file of 3D model conversion was used for production. The porosity of the designed stent was 70% and the pore size was 500μm. The 3D printed porous titanium alloy stent was obtained by 3D printing;

[0034] 2) Dissolve chitosan in 1% acetic acid to prepare chitosan solution, and dissolve 0.1 g of β-glycerophosphate powder in 2 mL of 60% ethanol to prepare 50 g / L β-glycerophosphate solution;

[0035] 3) The hydrogel was prepared by mixing chitosan and β-glycerophosphate solution and then vigorously stirring at room temperature for 10 minutes, then pouring 3 mL of the mixed solution into a 35 mL plastic culture dish and placing it in an incubator at 37°C for 48 hours, adding 5 mL of 10 g / L glycine solution to the cross-linked gel, followed by incubation for 2 hours to bind unreacted β-glycerophosphate, then draining the glycine solution and washing the gel 3 times with triple distilled water to obtain chitosan hydrogel.

[0036] The 3D printed porous titanium alloy scaffold is a 3D printing machine that puts 45-55μm Ti-6Al-4v powder. The scaffold is divided into two types: a disc-shaped φ4×L8 mm for cell experiments and a cylindrical φ10×L3 mm for animal experiments. The obtained 3D printed porous titanium alloy scaffold is soaked in ethanol and ultrapure water for 45 minutes and circulated three times. The 3D printed porous titanium alloy scaffold needs to be autoclaved before use.

[0037] To evaluate the rate at which the composite scaffold releases the ICA, the composite scaffold was immersed in a 48-well culture plate containing 1 mL of buffer at 37° C., and then an equal amount of buffer was replaced at 1 hour, 4 hours, 10 hours, 24 hours, 72 hours, 168 hours, 240 hours, and 360 hours. The ICA concentration in the collected buffer was measured using a UV spectrophotometer, and three independent experiments were performed.

[0038] In this article, titanium alloy stents are represented by (Ti), β-glycerophosphate solution / chitosan hydrogel titanium alloy stents are represented by (GC-Ti), and β-glycerophosphate solution / chitosan hydrogel / icariin are represented by (ICA-GC-Ti).

[0039] The obtained scaffolds are divided into two sizes, and interconnected and regularly arranged pores can be seen inside. The diameter of the disc scaffold is 10 mm and the height is 3 mm; the diameter of the cylindrical scaffold is 4 mm and the height is 8 mm. The pore size is 500 μm and the porosity is about 70%. The thermosensitive chitosan hydrogel is liquid at low temperatures and transforms into a gel state when the temperature rises to 37°C in the human body. The 3D printing mark on the surface of the scaffold gives the scaffold a certain degree of roughness, which has a positive effect on improving the stability of the gel in the pores and increasing cell adhesion. Under a scanning electron microscope, the thermosensitive gel has an irregular porous structure, which is conducive to cell adhesion. The hydrogel is well filled in the pores of the scaffold.

[0040] Bone marrow mesenchymal stem cells (1x104 / well) were cultured with TI, GC-Ti, and ICA-GC-Ti on 48-well plates for 1 day and 4 days. Bone marrow mesenchymal stem cells were stained for live / dead at each time point, and the number of live and dead cells was observed under a fluorescence microscope. In order to more intuitively evaluate the changes in cell viability, Bone marrow mesenchymal stem cells were co-cultured with scaffolds for 1, 4, and 7 days, and CCK-8 assays were performed at each time point. Then, the absorbance value was measured at 450 nm using a Bio-Rad microplate reader. All experiments were performed three times independently.

[0041] Bone marrow mesenchymal stem cells (2x105 / well) were co-cultured with Ti, GC-Ti, and ICA-GC-Ti on 48-well plates for 7 and 14 days. Osteogenic medium was used to promote cell differentiation. Alkaline phosphatase staining was used on the 7th day and Alizarin red staining was used on the 14th day. After washing with PBS three times at the corresponding time, the cells were fixed with 4% paraformaldehyde for 30 min. The cells were incubated with the dye at room temperature for 30 min and then washed with PBS three times to eliminate background interference. The staining and the number of calcium nodules were observed under a light microscope to evaluate the osteogenesis.

[0042] like Figure 3 As shown, in this embodiment, the composite scaffold is immersed in a 48-well culture plate containing 1 mL of buffer at 37° C., and then an equal amount of buffer is replaced at 1 hour, 4 hours, 10 hours, 24 hours, 72 hours, 168 hours, 240 hours and 360 hours. The ICA concentration in the collected buffer is measured by a UV spectrophotometer. The hydrogel slowly degrades in the pores of the scaffold. According to the staining and weighing conditions, the hydrogel continues to degrade within 17 days. On the 17th day, the degradation rate reaches 91.33±0.58%. In addition, the staining on day 17 also shows that the gel has been basically degraded. The release time of ICA encapsulated in the hydrogel can reach 15 days. The release rate on the first day is the highest, which is 54.1±1.78%. After the explosive release of ICA on the first day (24 hours), the release rate gradually decreases and stabilizes. In the following days, ICA was released at a relatively stable rate for 15 days. On the 15th day, the release rate of ICA was 91.33±0.58%. The results showed that the thermosensitive hydrogel could effectively prolong the release time of ICA.

[0043] The biocompatibility of the composite scaffolds was evaluated by performing streptavidin / DAPI staining on bone marrow mesenchymal stem cells co-cultured with Ti, GC-Ti, and ICA-GC-Ti. The cells in the Ti group overlapped and lacked the corresponding cell morphology. The cells in the GC-Ti group had a preliminary extended structure that was not much different from the cells in the Ti group. The cells in the ICA-GC-Ti group had a complete stem cell morphology with an extended pseudopodia structure, and the cells formed a typical spindle shape. Therefore, ICA-GC-Ti had good biocompatibility and the lowest cytotoxicity to cells.

[0044] like Figure 4-5 As shown, in the present embodiment, bone marrow mesenchymal stem cells were co-cultured with the scaffold for 7 days and 14 days. Alkaline phosphatase staining and alizarin red staining were used to visually evaluate the osteogenic differentiation degree of bone marrow mesenchymal stem cells. On the 7th day, the alkaline phosphatase staining results showed significant differences. Subsequent alizarin red staining also showed the same results on the 14th day. At two time points, the osteogenic differentiation effect of the ICA-GC-Ti group was the strongest, and larger calcified nodules were visible in each group on the 14th day. The calcified area of ​​ICA-GC-Ti on the 14th day was 3.11 ± 0.03 times and 9.21 ± 0.04 times higher than that of GC-Ti and Ti groups.

[0045] The expression of osteogenic differentiation-related genes in BMSCs was detected, and the expression levels of BMP-2 and cyanate genes were evaluated to reflect the effect of the composite scaffold on the osteogenic differentiation of BMSCs. On the 7th and 14th days, the expression of osteogenic-related genes in the ICA-GC-Ti group was the highest. ALP is an important marker of early osteogenesis and can represent the early differentiation of BMSCs into osteoblasts. Compared with the 7th day, the expression of ALP gene in each group decreased slightly on the 14th day, but the expression level in the ICA-GC-Ti group was still the highest. The expression levels of BMP-2 and cyanate showed a consistent trend, both showing an increasing trend. On the 7th and 14th days, the expression of cyanate in the ICA GC Ti group was 1.71±0.05 times and 2.13±0.06 times that of the Ti group, respectively. In summary, the RT qPCR results showed that ICA-GC-Ti could significantly promote the osteogenic differentiation of BMSCs.

[0046] Composite scaffold-sized bone defects were prepared in the lateral epicondyle of rabbit femur and successfully implanted. During the feeding process, no infection or death occurred in the rabbits. At 6 and 12 weeks after surgery, the distal specimens of the implanted scaffolds of rabbits in each group were randomly selected. Mechanical experiments were performed to evaluate the bonding strength between the scaffold and the host bone interface. The bonding strength of the ICA-GC-Ti group was the highest at 6 weeks. In addition, the bonding strength of each group improved during the period of 6 to 12 weeks, but the ICA-GC-Ti group had the greatest improvement. At the 6th and 12th weeks, the maximum thrust of the ICA-GC-Ti group was 15.98±5.11 N and 135.92±12.12 N, respectively, which were greater than the Ti group. Through the introduction of mechanics, it was found that ICA-GC-Ti can effectively improve the integration of the prosthesis and bone interface.

[0047] like Figure 6-7 As shown, in this embodiment, the final concentration of ICA in the composite scaffold is 0.1 μmol / mL, and then a cyclic freeze-drying treatment is performed. The microscopic characteristics and structure of the obtained freeze-dried samples are observed under a scanning electron microscope, and the rate at which the composite scaffold releases the ICA is evaluated. The composite scaffold is immersed in a 48-well culture plate containing 1 mL of buffer at 37°C, and then an equal amount of buffer is replaced at 1 hour, 4 hours, 10 hours, 24 hours, 72 hours, 168 hours, 240 hours and 360 hours. The ICA concentration in the collected buffer is measured by an ultraviolet spectrophotometer, and three independent experiments are performed. The osteogenesis of the scaffold interface is visually observed and analyzed through images. At week 6, the bone regeneration amount of ICA-GC-Ti is slightly higher than that of GC-Ti and Ti, and the difference increases at week 12. According to data analysis, the bone volume fraction, trabecular thickness, and trabecular quantity content in the ICA-GC-Ti group are higher than those in the other two groups. The difference between the three groups increased significantly at 12 weeks. The separation of trabeculae in the ICA-GC-Ti group was slightly lower than that in the other two groups. The results of immunohistochemical staining directly showed bone regeneration at the junction of local bone and scaffold. We observed bone regeneration markers and cyanate. The staining of bone regeneration markers and cyanate in the ICA-GC-Ti group was better than that in the GC-Ti group and the Ti group at 6 and 12 weeks. The expression levels of bone regeneration markers and cyanate were significantly increased at 12 weeks compared with 6 weeks.

[0048] The technical solution provided by the present invention is that the weight of the hydrogel no longer changes from the 17th day, but the hydrogel is not completely degraded. The reason for this phenomenon is that it is difficult to remove the hydrogel attached to the surface of the scaffold. The degradation curve shows that the degradation process is uniform, which is conducive to the slow release of ICA. The degradation of the hydrogel in the scaffold provides bone integration at the interface of the prosthesis and the host bone. The release of ICA is manifested as a large amount of early release and subsequent stable release. The pore size of the scaffold is a direct factor leading to drug release. A larger pore size will accelerate the loss of the drug. Therefore, the early release may be due to the outflow of ICA from the pores. In the subsequent period of time, the release rate is less affected by the pore size. The stable release rate at this stage may be due to the slow degradation of the hydrogel. ICA in the hydrogel can be continuously released within 15 days. Therefore, this structure is a good local drug delivery method to promote bone regeneration and bone integration. At the 6th and 12th weeks, the maximum extrusion pressures of the ICA-GC-Ti group were 15.98±5.11 N and 135.92±12.12 N, respectively, which were greater than those of the Ti group. The mechanical experiment directly reflects the tightness of the scaffold combined with the host bone. The results show that ICA-GC-Ti effectively promotes the bone integration of the scaffold. The locally released ICA can effectively promote the proliferation and osteogenic differentiation of bone marrow mesenchymal stem cells and improve the early stability of the scaffold-bone interface. Adding ICA / thermosensitive chitosan hydrogel to three-dimensional porous implants is an effective strategy to enhance bone regeneration and bone integration.

[0049] The present invention covers any substitution, modification, equivalent method and scheme made on the essence and scope of the present invention. In order to make the public have a thorough understanding of the present invention, specific details are described in detail in the following preferred embodiments of the present invention, but those skilled in the art can fully understand the present invention without the description of these details. In addition, in order to avoid unnecessary confusion about the essence of the present invention, well-known methods, processes, procedures, components and circuits are not described in detail.

[0050] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.

Claims

1. A method for preparing a 3D printed titanium alloy porous implant carrying functionalized thermosensitive chitosan hydrogel. It is characterized in that The following steps are involved: 1) Ti-6Al-4v powder was prepared by electron beam molten deposition technology under the action of standard running files converted from 3D models. The porosity of the designed scaffold was 70% and the pore size was 500μm. A 3D printed porous titanium alloy scaffold was obtained by 3D printing; 2) Chitosan was dissolved in 1% acetic acid to prepare a chitosan solution, and 0.1g of β-glycerophosphate powder was dissolved in 2mL of 60% ethanol to prepare a 50g / L β-glycerophosphate solution; 3) The hydrogel was prepared by mixing chitosan and β-glycerophosphate solution and then vigorously stirring at room temperature for 10 minutes, then 3mL of the mixed solution was poured into a 35mL plastic culture dish and placed in an incubator at 37°C for 48 hours, 5mL of 10g / L glycine solution was added to the cross-linked gel, followed by incubation for 2 hours to bind unreacted β-glycerophosphate, then the glycine solution was drained and the gel was washed 3 times with triple distilled water to obtain a chitosan hydrogel.

2. The method for preparing the 3D printed titanium alloy porous implant carrying functionalized thermosensitive chitosan hydrogel according to claim 1, It is characterized in that The 3D printed porous titanium alloy scaffold is a 3D printing machine that puts 45-55μm Ti-6Al-4v powder. The scaffold is divided into two types: a disc-shaped φ4×L8 mm for cell experiments and a cylindrical φ10×L3 mm for animal experiments. The obtained 3D printed porous titanium alloy scaffold is soaked in ethanol and ultrapure water for 45 minutes and circulated three times. The 3D printed porous titanium alloy scaffold needs to be autoclaved before use.

3. The method for preparing a 3D printed titanium alloy porous implant carrying a functionalized thermosensitive chitosan hydrogel according to claim 1, It is characterized in that ICA is added into the liquid gel solution and mixed evenly to obtain a mixed solution, wherein the ICA is icariin, and the 3D printed porous titanium alloy stent is immersed in the mixed solution and allowed to stand at 37° C. for 20 minutes to obtain a composite stent after gelation.

4. The method for preparing the 3D printed titanium alloy porous implant carrying functionalized temperature-sensitive chitosan hydrogel according to claim 3, It is characterized in that The final concentration of ICA in the composite scaffold was 0.1 μmol / mL, and then a cyclic freeze-drying process was performed, and the microscopic characteristics and structure of the obtained freeze-dried sample were observed under a scanning electron microscope.

5. The method for preparing the 3D printed titanium alloy porous implant carrying functionalized thermosensitive chitosan hydrogel according to claim 3, It is characterized in that To evaluate the rate at which the composite scaffold releases the ICA, the composite scaffold was immersed in a 48-well culture plate containing 1 mL of buffer at 37°C, and then an equal amount of buffer was replaced at 1 hour, 4 hours, 10 hours, 24 hours, 72 hours, 168 hours, 240 hours and 360 hours. The ICA concentration in the collected buffer was measured using a UV spectrophotometer, and three independent experiments were performed.

Citation Information

Cited By

  • 3D printing titanium alloy implant with cell proliferation promoting capacity and preparation method and application thereof

    CN119909227A

  • 3D-printed titanium alloy implant with the ability to promote cell proliferation and preparation method and application thereof

    CN119909227B